NCT00090259View on ClinicalTrials.gov

Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)

PHASE3CompletedINTERVENTIONAL
Enrollment

3,834

Participants

Timeline

Start Date

December 19, 2001

Primary Completion Date

March 31, 2009

Study Completion Date

May 13, 2009

Conditions
Heart Failure
Interventions
DRUG

Losartan 50 mg

50-mg losartan oral tablet

DRUG

Losartan 150 mg

100-mg losartan oral tablet + 50-mg losartan oral tablet

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00090259 - Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948) | Biotech Hunter | Biotech Hunter